当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:95.95亿  总市值:95.95亿
流通股本:4.16亿   总股本:4.16亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金296,261,586.871,455,173,088.821,012,333,409.43657,961,769.62
  收到的税费返还-554,299.08554,299.08780,714.19
  收到其他与经营活动有关的现金5,949,620.7541,240,351.0532,031,729.7424,556,465.53
  经营活动现金流入小计302,211,207.621,496,967,738.951,044,919,438.25683,298,949.34
  购买商品、接受劳务支付的现金46,585,177.77293,141,344.99214,480,984.36121,092,610.35
  支付给职工以及为职工支付的现金129,815,764.75356,237,957.68280,110,219.89208,200,900.16
  支付的各项税费29,831,559.7494,843,144.4489,859,118.1443,715,463.39
  支付其他与经营活动有关的现金76,331,472.76411,880,359.34289,451,134.88183,809,029.85
  经营活动现金流出小计282,563,975.021,156,102,806.45873,901,457.27556,818,003.75
  经营活动产生的现金流量净额19,647,232.6340,864,932.5171,017,980.98126,480,945.59
二、投资活动产生的现金流量:
  收回投资收到的现金1,380,000,0004,747,395,334.713,504,395,334.712,329,320,000
  取得投资收益收到的现金8,524,864.2127,162,732.4822,040,132.614,136,811
  处置固定资产、无形资产和其他长期资产收回的现金净额-3,432.043,500-
  投资活动现金流入小计1,388,524,864.214,774,561,499.233,526,438,967.312,343,456,811
  购建固定资产、无形资产和其他长期资产支付的现金49,592,622.29308,083,084.73251,993,518.47182,317,662.14
  投资支付的现金2,030,000,0004,593,000,0003,589,000,0002,799,000,000
  支付其他与投资活动有关的现金20,323.81356,995.14344,000.62264,510.84
  投资活动现金流出小计2,079,612,946.14,901,440,079.873,841,337,519.092,981,582,172.98
  投资活动产生的现金流量净额-691,088,081.89-126,878,580.64-314,898,551.78-638,125,361.98
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金28,000329,234,779.84329,224,279.84329,224,279.84
  支付其他与筹资活动有关的现金-17,298,546.3514,264,291.733,034,254.62
  筹资活动现金流出小计28,000346,533,326.19343,488,571.57332,258,534.46
  筹资活动产生的现金流量净额-28,000-346,533,326.19-343,488,571.57-332,258,534.46
四、汇率变动对现金及现金等价物的影响-925,002.16685,773.15970,746.96980,417.67
五、现金及现金等价物净增加额-672,393,851.45-131,861,201.18-486,398,395.41-842,922,533.18
  加:期初现金及现金等价物余额4,366,190,245.614,498,051,446.794,498,051,446.794,498,051,446.79
  期末现金及现金等价物余额3,693,796,394.164,366,190,245.614,011,653,051.383,655,128,913.61
补充资料:
  净利润-131,790,329.4-122,294,675.25
  资产减值准备-132,085,345.56-16,369,205.15
  固定资产和投资性房地产折旧-166,147,055.41-79,264,838.3
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-166,147,055.41-79,264,838.3
  无形资产摊销-7,470,377.59-3,572,592.27
  长期待摊费用摊销-4,138,256.52-2,069,128.26
  处置固定资产、无形资产和其他长期资产的损失-601.76--
  固定资产报废损失-507,215.87-278,061.06
  公允价值变动损失--63,167,530.34-2,669,752.62
  财务费用--80,113.26--650,644.23
  投资损失--15,934,307.61--13,267,031.43
  递延所得税-1,517,889.46--11,743,323.95
  其中:递延所得税资产减少-1,555,345.19--11,639,468.05
    递延所得税负债增加--37,455.73--103,855.9
  存货的减少--52,759,125.42--16,577,383.02
  经营性应收项目的减少-18,388,212.19--71,066,385.17
  经营性应付项目的增加--2,714,426.02--5,495,052.05
  其他-127,951.14-32,466.84
  现金的期末余额-4,366,190,245.61-3,655,128,913.61
  减:现金的期初余额-4,498,051,446.79-4,498,051,446.79
  现金及现金等价物的净增加额--131,861,201.18--842,922,533.18
公告日期2026-04-292026-04-212025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑